Prof. Charles Craddock, CBE, discusses paradigm trial, transplant advances at ASH 2025

Prof. Charles Craddock, CBE, professor of hematology-oncology at the University of Birmingham and consultant hematologist at University Hospitals Birmingham, shares his thoughts on the ASH 2025 meeting, including trial results from the paradigm study.

Watch more from ASH 2025